“…Besides, the morphology of nanomedicines influences their fate in vivo, which the anisotropic nanostructures have been proved to exhibit longer blood circulation time and higher retention in tumor sites 22,23 . Basically, the morphology and size of MIONs can be controlled by modulating the synthetic parameters (eg, iron precursors, surfactants, solvent, pH value, dopants, reaction temperature, and duration) 15,24,25 . Figure 1 shows several representative MIONs that have been reported in recent years.…”